Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Arthritis Rheum. 2012 Aug;64(8):2773–2780. doi: 10.1002/art.34458

Table 4.

Relative hazard of hospitalized bacterial infection.

JIA medication exposure group Referent Group Unadjusted Relative Hazard (95% CI) Adjusted* Relative Hazard (95% CI)
JIA: no current MTX, no current TNF inhibitor ADHD 3.3 (2.6–4.1) 2.0 (1.5–2.5)
JIA: current MTX, no current TNF inhibitor JIA: no current MTX, no current TNF inhibitor 1.3 (1.0–1.7) 1.2 (0.9–1.7)
JIA: current TNF inhibitor, irrespective of MTX JIA: current MTX, no current TNF inhibitor 1.3 (0.9–1.9) 1.2 (0.8–1.8)

JIA = juvenile idiopathic arthritis; ADHD = attention-deficit hyperactivity disorder; MTX = methotrexate or leflunomide; TNF inhibitor = etanercept, infliximab, or adalimumab; GC = glucocorticoids

*

Adjusted for patient age, sex, race, hospitalized bacterial infection during baseline, outpatient bacterial infection during baseline, asthma, diabetes mellitus, GC dose on index date (none, low (< 10 mg prednisone equivalents per day), or high (≥ 10 mg prednisone equivalents per day)).